
Jeff Bezos creating AI startup
Wall Street Breakfast
00:00
Novo Nordisk Prices to Challenge Eli Lilly
Kim Kahn outlines Novo Nordisk's price cuts for obesity drugs Lagarv and Ozempic to regain U.S. market share.
Play episode from 01:33
Transcript


